Form 4: Surgery Partners CEO Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Surgery Partners CEO Jason Eric Evans sold 26,520 shares of common stock on February 7, 2025, to satisfy tax withholding obligations related to the vesting of restricted stock.
Summary
- On February 7, 2025, Jason Eric Evans, the CEO of Surgery Partners, Inc. (SGRY), sold 26,520 shares of the company's common stock.
- The shares were sold at a weighted average price of $25.65 per share.
- This transaction was executed to cover Mr. Evans' tax withholding obligations in connection with the vesting of restricted stock on January 31, 2025.
- Following the transaction, Mr. Evans still beneficially owns 560,698 shares of Surgery Partners, Inc.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (selling shares to cover tax obligations). It's neutral in sentiment.
Industry Context
Sales of shares to cover tax obligations are a routine part of executive compensation, particularly when dealing with equity-based compensation.
Stakeholder Impact
- The sale of shares by the CEO could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.
Key Dates
| Date | Description |
|---|---|
| January 31, 2025 | Restricted stock vested, triggering tax obligations. |
| February 07, 2025 | Date of stock sale by Jason Eric Evans. |
| February 10, 2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.